Welcome

Cutting the cost of medicines in Europe 


A word of welcome from the EAEPC President

Dear Visitor,


Do you like the idea of saving money when making a purchase? Do you want to be assured that the product you are buying is safe? Do you expect a product to be available when you want and need it most?


If you answered yes to the above questions, then you will find the idea of parallel trade attractive.

And this is no different when it comes to a special product like a medicine.

Payers for prescription medicines in numerous member states of the EU – be they governments, national health services, sickness funds or patients – are already convinced. For over 20 years they have received guaranteed savings from the spread of parallel trade, which brings competition to an otherwise closed market.

The medicines traded are those of the original manufacturers, sourced exclusively from inside Europe, and checked thoroughly by the relevant regulatory authorities. They are often produced in the same manufacturing plants and are sold through the same channels as essentially identical products marketed by the domestic trademark owner – but they are cheaper.

The European Association of Euro-Pharmaceutical Companies (EAEPC), representing parallel traders in medicines across Europe, welcomes you to its website and invites you to find out more.

Best wishes